243 related articles for article (PubMed ID: 16809147)
21. Low incidence of SV40-like sequences in ependymal tumours.
Reuther FJ; Löhler J; Herms J; Hugo HH; Schindler C; Leithäuser F; Melzner I; Möller P; Scheil S
J Pathol; 2001 Dec; 195(5):580-5. PubMed ID: 11745694
[TBL] [Abstract][Full Text] [Related]
22. Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia.
Sui LF; Williamson J; Lowenthal RM; Parker AJ
Pathology; 2005 Apr; 37(2):157-9. PubMed ID: 16028845
[TBL] [Abstract][Full Text] [Related]
23. Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.
Engels EA; Chen J; Hartge P; Cerhan JR; Davis S; Severson RK; Cozen W; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):521-4. PubMed ID: 15734981
[TBL] [Abstract][Full Text] [Related]
24. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine.
Rollison DE; Page WF; Crawford H; Gridley G; Wacholder S; Martin J; Miller R; Engels EA
Am J Epidemiol; 2004 Aug; 160(4):317-24. PubMed ID: 15286016
[TBL] [Abstract][Full Text] [Related]
25. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes.
Shivapurkar N; Takahashi T; Reddy J; Zheng Y; Stastny V; Collins R; Toyooka S; Suzuki M; Parikh G; Asplund S; Kroft SH; Timmons C; McKenna RW; Feng Z; Gazdar AF
Cancer Res; 2004 Jun; 64(11):3757-60. PubMed ID: 15172980
[TBL] [Abstract][Full Text] [Related]
26. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
Olin P; Giesecke J
Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
[TBL] [Abstract][Full Text] [Related]
27. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
[TBL] [Abstract][Full Text] [Related]
28. Review of prevalence of Simian Virus 40 (SV40) genomic infection in healthy subjects.
Paracchini V; Garte S; Pedotti P; Taioli E
Mutat Res; 2006 Mar; 612(2):77-83. PubMed ID: 16081314
[TBL] [Abstract][Full Text] [Related]
29. Is the simian virus SV40 associated with idiopathic focal segmental glomerulosclerosis in humans?
Galdenzi G; Lupo A; Anglani F; Perini M; Galeazzi L; Giunta S; Marcantoni C; Del Prete D; Graziotto R; D'angelo A; Maschio G; Gambaro G
J Nephrol; 2003; 16(3):350-6. PubMed ID: 12832733
[TBL] [Abstract][Full Text] [Related]
30. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas.
Hernández-Losa J; Fedele CG; Pozo F; Tenorio A; Fernández V; Castellví J; Parada C; Ramón y Cajal S
Cancer; 2005 Jan; 103(2):293-8. PubMed ID: 15593086
[TBL] [Abstract][Full Text] [Related]
31. Simian virus 40 footprints in normal human tissues, brain and bone tumours of different histotypes.
Martini F; Lazzarin L; Iaccheri L; Corallini A; Gerosa M; Trabanelli C; Calza N; Barbanti-Brodano G; Tognon M
Dev Biol Stand; 1998; 94():55-66. PubMed ID: 9776226
[TBL] [Abstract][Full Text] [Related]
32. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.
Engels EA
Expert Rev Vaccines; 2005 Apr; 4(2):197-206. PubMed ID: 15889993
[TBL] [Abstract][Full Text] [Related]
33. Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas.
Priftakis P; Bogdanovic G; Hjerpe A; Dalianis T
Anticancer Res; 2002; 22(3):1357-60. PubMed ID: 12168811
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
[TBL] [Abstract][Full Text] [Related]
35. [SV40 as a possible cofactor in the etiopathogenesis of mesothelioma and other human tumors].
Barbanti-Brodano G; Trabanelli C; Lazzarin L; Martini F; Merlin M; Calza N; Corallini A; Tognon M
G Ital Med Lav Ergon; 1998; 20(4):218-24. PubMed ID: 9987613
[TBL] [Abstract][Full Text] [Related]
36. SV40 sequences in human osteosarcoma of German origin.
Heinsohn S; Scholz RB; Weber B; Wittenstein B; Werner M; Delling G; Kempf-Bielack B; Setlak P; Bielack S; Kabisch H
Anticancer Res; 2000; 20(6B):4539-45. PubMed ID: 11205301
[TBL] [Abstract][Full Text] [Related]
37. SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.
Magnani C
Med Lav; 2005; 96(4):347-53. PubMed ID: 16457431
[TBL] [Abstract][Full Text] [Related]
38. Virology. Monkey virus link to cancer grows stronger.
Ferber D
Science; 2002 May; 296(5570):1012-5. PubMed ID: 12004103
[No Abstract] [Full Text] [Related]
39. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.
Engels EA; Katki HA; Nielsen NM; Winther JF; Hjalgrim H; Gjerris F; Rosenberg PS; Frisch M
J Natl Cancer Inst; 2003 Apr; 95(7):532-9. PubMed ID: 12671021
[TBL] [Abstract][Full Text] [Related]
40. Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? An age-period-cohort analysis on Norwegian data from 1953 to 1997.
Thu GO; Hem LY; Hansen S; Møller B; Norstein J; Nøkleby H; Grotmol T
Int J Cancer; 2006 Apr; 118(8):2035-9. PubMed ID: 16287082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
